TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/5/24 17:15 | 1/4/24 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Chiniara Ellen | MA | O | GC | S | -74 | 22.58 | 0 | -3 | -9 | 34 | D | ||||||||||||||
9/5/17 19:43 | 8/31/17 | ALR | Alere Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Chiniara Ellen | MA | O | GC,Chief | M.d | 0 | 0.00 | 0 | 7 | 26 | 33 | D | ||||||||||||||
2/21/17 18:08 | 2/16/17 | ALR | Alere Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Chiniara Ellen | MA | O | GC,Chief | M.d | 0 | 0.00 | 23 | 10 | 53 | 28 | D | -8 | -25 | 0 | 5 | 2 | 8 | 4 | -1 | 0 | -1 | -4 | |||
10/18/16 17:40 | 10/14/16 | ALR | Alere Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Chiniara Ellen | MA | O | GC,Chief | M.d | 944 | 37.74 | 21 | 25 | 22 | D | 17 | -10 | -14 | -2 | 6 | -2 | -3 | -1 | 2 | 6 | -15 | -5 | 15 | ||
9/13/16 17:23 | 9/9/16 | ALR | Alere Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Chiniara Ellen | MA | O | GC,Chief | M.d | 0 | 0.00 | 33 | 7 | 76 | 15 | D | 17 | -18 | -20 | 1 | 16 | 7 | 10 | 2 | 0 | 2 | 0 | -12 | -14 | |
9/2/15 16:53 | 8/31/15 | ALR | Alere Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Chiniara Ellen | MA | O | GC,Chief | M.d | 0 | 0.00 | 33 | 7 | 359 | 9 | D | 64 | 41 | 11 | -2 | -2 | -5 | -4 | -3 | 0 | 1 | -4 | -20 | 4 | -25 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |